Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartflow, Inc. - Common Stock (NQ:HTFL)

27.40 +0.58 (+2.16%)
Streaming Delayed Price Updated: 2:47 PM EDT, Mar 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Heartflow, Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares? ↗
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools. 
Via The Motley Fool
Heartflow Inc (NASDAQ:HTFL) Reports Strong Q4 Revenue Beat and Improved Margins Despite After-Hours Share Decline ↗
Via Chartmill
News headline image
Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes
NBA legend Muggsy Bogues joins effort to detect and manage coronary artery disease in retired players using AI-powered Heartflow Analysis 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes ↗
CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
AI Diagnostics: The End of the High-Cost Imaging Era
Issued on behalf of VentriPoint Diagnostics Ltd. 
From Equity Insider
Via GlobeNewswire
News headline image
Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S.
Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Is Recent IPO Stock Heartflow a Buy After a Director Scooped Up Shares Worth Over $1 Million? ↗
AI-powered cardiac diagnostics firm HeartFlow reported a recent insider buy, as disclosed in the latest SEC filing. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
Why AI Stock HeartFlow Triumphed on Thursday ↗
A key FDA-cleared analysis tool earned professional accolades for its utility. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD
Reinforces Role of AI-Powered Quantitative Coronary Plaque Assessment 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
This Family Office Acquired $148 Million of Karman Stock as Shares Tripled Since February IPO ↗
One family office fund just made Karman its biggest reported equity bet—here’s what long-term investors should take from the move. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO ↗
A billionaire family office has made a big bet on a newly public AI-driven heart diagnostics company—here’s what long-term investors should take from the move. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million ↗
Bain Capital added more than 12.4 million shares of HeartFlow stock in the thrid quarter 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer ↗
Bain Capital's bet on Cidara Therapeutics stocks has paid off in a big way 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Biotech Stock Gets Booted in Latest Fund Update ↗
Bain Capital sold its entire stake in Nuvalent stock during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗
Bain Capital completely exited its position in Disc Medicine stock during the third quarter 
Via The Motley Fool
News headline image
Why Bain Capital Is Selling Shares of This Biotech Stock Now ↗
Bain Capital sold $20 million worth of Pharvaris stock during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Where Innovation Meets the Heart: Stanford’s New Position in HeartFlow ↗
Stanford just bought into HeartFlow. Here is what caught Stanford’s eye and what investors need to know about HeartFlow’s early trajectory and long-term potential. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Heartflow Inc (NASDAQ:HTFL) Posts Mixed Q3 2025 Results with Strong Revenue Beat and Upbeat Guidance ↗
Heartflow Q3 2025 earnings show strong revenue growth, beating estimates, and confident full-year guidance. 
Via Chartmill
News headline image
Heartflow Reports Third Quarter 2025 Financial Results
Initiates Full Year 2025 Revenue Guidance of $173.0 Million to $173.5 Million 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification
Multicenter outcomes FISH&CHIPS study of nearly 8,000 patients confirms total plaque volume as a powerful independent predictor of long-term cardiovascular events 
From Heartflow, Inc.
Via GlobeNewswire
News headline image
Alpha Buying: 118 Years of Finding World-Changing Stocks ↗
 
Via Benzinga
News headline image
Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025
Data to highlight the precision of AI-powered Heartflow Plaque Staging framework in predicting long-term cardiovascular outcomes 
From Heartflow, Inc.
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.